Nov 15 (Reuters) – Johnson & Johnson could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
TOKYO, Nov 16 (Reuters) - Japan's Nikkei share average slumped on Monday, dragged down by…
By Makiko Yamazaki and Satoshi Sugiyama TOKYO, Nov 16 (Reuters) - Japan's economy unexpectedly shrank…
CHINA STATS BUREAU SPOKESPERSON: POSITIVE CHANGES IN CHINA'S PROPERTY MARKET, BUT MARKETS IN SOME REGIONS…
KUALA LUMPUR, Nov 16 (Reuters) - Malaysian palm oil futures opened lower on Monday, snapping…
Jalen Brunson hit the tie-breaking 3-pointer with 33 seconds left in overtime for the visiting…
(Adds details, background from paragraph 2) Nov 16 (Reuters) - China's crude steel output fell…